Tracey McLaughlin, MD
Enriched profileProfessor of Medicine (Endocrinology) · Stanford University School of Medicine
Tracey McLaughlin is Professor of Medicine (Endocrinology) at Stanford University School of Medicine. OpenAlex indexes 175 publications with 14,010 citations (h-index 52); ClinicalTrials.gov lists 16 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Tracey McLaughlin, MD, is Professor of Medicine (Endocrinology) at Stanford University School of Medicine, Division of Endocrinology, Gerontology & Metabolism. The public record shows 175 publications with 14,010 citations (h-index 52), centered on Adipokines, Inflammation, and Metabolic Diseases, Diabetes, Cardiovascular Risks, and Lipoproteins, Adipose Tissue and Metabolism. It also documents an investigator role on 16 registered clinical trials, industry payments reported by 9 companies, 7 NIH-funded awards (2000–2026).
- Most recent indexed publication: 2026 · Journal of diabetes science and technology
- Top research focus: Adipokines, Inflammation, and Metabolic Diseases
- 16 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 11 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 106.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 16 registered studies on ClinicalTrials.gov. The most recent:
- Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
Sponsor: Stanford University
- Improving Glycemic Control Using a Virtual Weight Control Program and Continuous Glucose Monitoring
Sponsor: Pennington Biomedical Research Center
Industry payments
Updated 27 Aug 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Regeneron Pharmaceuticals, Inc.Program year20258 payments
- Dexcom, Inc.Program year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
66.9%GLP-1 receptor agonist25.2%Mounjaro36%Ozempic34%Trulicity31%Part D<11 patientsInsulin Analog19.3%Lantus Solostar28%Insulin Lispro Kwikpen U-10016%Novolog Flexpen15%Humalog Kwikpen U-10014%Novolog14%Toujeo Solostar12%Part D<11 patientsCardiovascular
18.5%Statin16.3%Pravastatin Sodium35%Rosuvastatin Calcium34%Atorvastatin Calcium31%Part D<11 patientsAngiotensin receptor blocker (ARB)2.2%Losartan Potassium100%Part D<11 patientsHormonal (systemic)
12.2%Antihypoglycemic Agent9.6%Baqsimi43%Gvoke Hypopen 2-Pack35%Glucagon Emergency Kit22%Part D<11 patientsl-Thyroxine2.6%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
7 NIH research awards on record, funded 2000–2026 per NIH RePORTER. The latest:
- Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention
Stanford University
FY2026$714,298R01DK139472 - Rapid Gastric Emptying: A Modifiable Risk Factor for Postbariatric Hypoglycemia
Stanford University
FY2026$681,391R01DK143214 - Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention
Stanford University
FY2025$714,440R01DK139472
Congress activity
Updated 27 Aug 2026
21 congress contributions (2019–2025) across ADA, ENDO per OpenAlex. The most recent:
- 2049-LB: Evaluating a Flexible, AI-Supported Digital Health Application for Glycemic Control and Weight Reduction—A Real-World Analysis
ADA Scientific Sessions
ADA2025Co-authorLate-breaking - MON-734 TIrzepatide Reverses Insulin Resistance Independent of Weight Loss in Individuals Without Diabetes
ENDO Annual Meeting
ENDO2025Presenting author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Use of Continuous Glucose Monitoring With Machine Learning to Identify Metabolic Subphenotypes and Inform Precision Lifestyle Changes.
Journal of diabetes science and technology
Review2026 - Integrating the Glycemia Risk Index Into Clinical Practice and Research: A Consensus Report.
Journal of diabetes science and technology
Article2026 - Modifiable Factors Affecting the Postprandial Glycemic Response.
Journal of diabetes science and technology
Review2026 - Continuous Glucose Monitoring in Patients With Postbariatric Hypoglycemia: Effect on Hypoglycemia and Quality of Life.
Journal of the Endocrine Society
Article2025 - Individual variations in glycemic responses to carbohydrates and underlying metabolic physiology.
Nature medicine
Article2025
Most-cited works
by citation count (OpenAlex)- 01
- 02Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin ResistantArticle1,040 citations2003
- 03
- 04Longitudinal multi-omics of host–microbe dynamics in prediabetesArticle617 citations2019
- 05Relationship between obesity, insulin resistance, and coronary heart disease riskArticle578 citations2002
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/tracey-mclaughlin-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Tracey-Mclaughlin
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/tracey-mclaughlin-08748b19
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Other
biox.stanford.edu/video/usrp-2025-obesity-and-insulin-resistance-focus-fat-cell
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biox.stanford.edu ↗ - Other
sdrc.stanford.edu/tracey-mclaughlin
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sdrc.stanford.edu ↗ - Other
pri-med.com/globals/faculty/m/mclaughlin-tracey
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pri-med.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- Residency
Internal Medicine, Santa Clara Valley Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biox.stanford.edu ↗ - Fellowship
Endocrinology, Diabetes, and Metabolism, Stanford University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biox.stanford.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
Secondary affiliations
appointments beyond the home institution- Bio-X Affiliated Faculty
Stanford University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biox.stanford.edu ↗ - Faculty
Stanford Nutrition and Obesity Research Center (NORC)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →norc.stanford.edu ↗ - Affiliated faculty
Center for Asian Health Research and Education (CARE), Stanford University
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asianhealth.stanford.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu ↗
- Referenced in Stanford Medicine News: "Diabetic-level glucose spikes seen in healthy people" (July 2018)
covering CGM research in her area of focus
2018provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.stanford.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Heidenreich, MD
Stanford University School of Medicine
Alan Schatzberg, MD
Stanford University School of Medicine
Mark Pegram, MD
Stanford University School of Medicine
Vibeke Strand, MD
Stanford University School of Medicine